Ko Soyoung, Ahn Jungmi, Song Chung S, Kim Soyoung, Knapczyk-Stwora Katarzyna, Chatterjee Bandana
Department of Molecular Medicine/Institute Biotechnology, The University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, Texas 78245, USA.
Mol Endocrinol. 2011 Mar;25(3):433-44. doi: 10.1210/me.2010-0482. Epub 2011 Jan 27.
Lysine methyltransferases modulate activities of transcription factors and transcription coregulators by methylating specific lysine residue(s). We report that the androgen receptor (AR) is methylated at lysine-630 by Set9, which was originally identified as a histone H3K4 monomethyltransferase. Alanine substitution of lysine-630 prevented AR methylation in vitro and in vivo. Set9 methylated the nuclear and cytoplasmic AR utilizing the cofactor S-adenosyl-methionine. A pan-methyllysine antibody recognized endogenous AR, and Set9 coimmunoprecipitated with nuclear and cytoplasmic AR. Set9 overexpression potentiated AR-mediated transactivation of the probasin promoter, whereas Set9 depletion inhibited AR activity and target gene expression. Similar to AR, chromatin occupancy of Set9 at androgen response elements (AREs) was androgen dependent, and associated with methylated histone H3K4 chromatin activation marks and p300/CBP associated factor acetyltransferase recruitment. Set9 depletion increased the histone H3K9-dimethyl repressive mark at AREs and reduced histone activation marks and occupancy of p300/CBP associated factor. K630A mutation reduced amino- and carboxy-terminal (N-C) interaction in Set9-intact cells, whereas N-C interaction for wild-type AR was reduced upon Set9 depletion. The K630A mutant was resistant to loss of activity from Set9 silencing and to increase of activity from Set9 overexpression. The K630 dependence of Set9-regulated N-C interaction and AR activity suggests that Set9 directly acts on AR at the amino acid level. Chromatin recruitment of Set9 to AREs is suggestive of its additional role as a transcriptional coactivator. Because the cellular metabolic state determines the level of S-adenosylmethionine and consequently the activity of Set9, the enhanced activity of methylated AR may have special significance in certain metabolic contexts.
赖氨酸甲基转移酶通过甲基化特定赖氨酸残基来调节转录因子和转录共调节因子的活性。我们报告称,雄激素受体(AR)在赖氨酸-630位点被Set9甲基化,Set9最初被鉴定为组蛋白H3K4单甲基转移酶。赖氨酸-630的丙氨酸替代在体外和体内均阻止了AR的甲基化。Set9利用辅因子S-腺苷甲硫氨酸使细胞核和细胞质中的AR甲基化。一种泛甲基赖氨酸抗体可识别内源性AR,且Set9与细胞核和细胞质中的AR进行共免疫沉淀。Set9的过表达增强了AR介导的前列腺素启动子的反式激活,而Set9的缺失则抑制了AR活性和靶基因表达。与AR相似,Set9在雄激素反应元件(AREs)处的染色质占据情况是雄激素依赖性的,并与甲基化组蛋白H3K4染色质激活标记以及p300/CBP相关因子乙酰转移酶的募集有关。Set9的缺失增加了AREs处组蛋白H3K9二甲基化抑制标记,并减少了组蛋白激活标记以及p300/CBP相关因子的占据情况。K630A突变降低了Set9完整细胞中氨基末端和羧基末端(N-C)的相互作用,而在Set9缺失时野生型AR的N-C相互作用则降低。K630A突变体对Set9沉默导致的活性丧失以及Set9过表达导致的活性增加具有抗性。Set9调节的N-C相互作用和AR活性对K630的依赖性表明,Set9在氨基酸水平上直接作用于AR。Set9募集到AREs的染色质表明其作为转录共激活因子具有额外作用。由于细胞代谢状态决定了S-腺苷甲硫氨酸的水平,进而决定了Set9的活性,甲基化AR增强的活性在某些代谢情况下可能具有特殊意义。